Effects of Evolocumab on Coronary Plaque Composition and Microcalcification Activity by Coronary PET and CT Angiography

By sjmartinez • April 4, 2025

Han D, Tzolos E, Park R, Gransar H, Hyun M, Friedman JD, Hayes SW, Thomson LEJ, Kwan AC, Budoff M, Shah PK, Kwieciński J, Wetzel S, Findling C, Slomka PJ, Dey D, Tamarappoo BK, Berman DS. Effects of Evolocumab on Coronary Plaque Composition and Microcalcification Activity by Coronary PET and CT Angiography. JACC Cardiovasc Imaging. 2025 Mar 23:S1936-878X(25)00090-7. doi: 10.1016/j.jcmg.2025.01.005. Epub ahead of print. PMID: 40178463.

Tags: (18)F-NaF PET, biomedical sciences, Cardiology/Epi, Cedars Sinai DoM, Computed Tomography Angiography, coronary artery disease, evolocumab, Harbor UCLA, plaque, Publications

Related Posts

Brief Report: Association of HIV and HCV With Adverse Coronary Artery Phenotypes in Women: Findings From a Cross-Sectional Study

Shitole SG, Chen E, Naveed M, Xue X, Sharma A, Hanna DB, Anastos K, Kaplan RC, Levsky JM, Tien PC, Radparvar AA, Bortnick AE, Budoff[...]

A microbiome quantitative trait locus in SLC39A8 modulates disease severity in synucleinopathy-induced models of Parkinson’s disease

Yang JC, Situ J, Troutman R, Zhu R, Black M, Buri H, Gutta A, Tian F, Kang A, Aja E, Zeng A, Lai RW, Tan[...]

Latency of Hypertensive Disorders of Pregnancy and Cardiovascular Risk 2-7 Years After Delivery

Shree S, Pike M, Yee LM, Levine L, Simhan H, Silver RM, Greenland P, Saade G, Bairey Merz CN, Chung J, Cleary EM, Grobman W,[...]